Letizia Cavallini
Papers
1
Total Citations
3
H-Index
1
About
Letizia Cavallini is at the forefront of applying artificial intelligence to radiation oncology, with a particular focus on improving treatment outcomes for prostate cancer patients. Her research centers on predictive modeling and the personalization of radiotherapy, aiming to reduce treatment-related toxicities through data-driven insights. In her landmark work, the ICAROS Study (2025), Cavallini led a multicenter initiative to develop a machine learning-based predictive model for acute gastrointestinal and genitourinary toxicity in patients undergoing salvage radiotherapy after prostatectomy. This study, already garnering 3 citations, represents a significant step toward integrating AI into clinical decision-making, identifying key prognostic factors that can guide more tailored and safer treatment plans. Her contributions are helping to bridge the gap between computational methods and patient care, offering a path toward minimizing side effects while maintaining therapeutic efficacy. Cavallini’s work is particularly impactful for oncologists and medical physicists seeking to harness machine learning for real-world clinical challenges, establishing her as a rising voice in the field of precision radiation therapy.
Research Focus
Key Achievements
Top Papers
- 1